BHK Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-557
Closed -$425K 74
2025
Q3
$425K Hold
557
0.16% 50
2025
Q2
$434K Buy
557
+10
+2% +$7.77K 0.17% 46
2025
Q1
$452K Sell
547
-991
-64% -$825K 0.19% 45
2024
Q4
$1.19M Sell
1,538
-48
-3% -$39.7K 0.45% 28
2024
Q3
$1.4M Buy
1,586
+28
+2% +$25.2K 0.52% 22
2024
Q2
$1.41M Hold
1,558
0.55% 23
2024
Q1
$1.21M Buy
1,558
+553
+55% +$394K 0.47% 28
2023
Q4
$586K Sell
1,005
-549
-35% -$320K 0.34% 27
2023
Q3
$835K Hold
1,554
0.38% 25
2023
Q2
$729K Sell
1,554
-209
-12% -$87.6K 0.31% 31
2023
Q1
$605K Buy
1,763
+476
+37% +$161K 0.26% 33
2022
Q4
$471K Buy
1,287
+657
+104% +$233K 0.26% 32
2022
Q3
$204K Sell
630
-1,201
-66% -$381K 0.1% 64
2022
Q2
$594K Buy
1,831
+4
+0.2% +$1.2K 0.27% 31
2022
Q1
$523K Buy
1,827
+5
+0.3% +$1.29K 0.22% 32
2021
Q4
$503K Buy
1,822
+4
+0.2% +$1.01K 0.2% 35
2021
Q3
$420K Buy
1,818
+4
+0.2% +$987 0.17% 41
2021
Q2
$416K Buy
1,814
+9
+0.5% +$1.81K 0.17% 40
2021
Q1
$305K Hold
1,805
0.14% 55
2020
Q4
$305K Buy
1,805
+5
+0.3% +$747 0.14% 53
2020
Q3
$266K Sell
1,800
-12
-0.7% -$1.86K 0.15% 52
2020
Q2
$297K Buy
1,812
+6
+0.3% +$921 0.18% 42
2020
Q1
$251K Buy
1,806
+6
+0.3% +$824 0.18% 42
2019
Q4
$237K Sell
1,800
-750
-29% -$86.9K 0.14% 60
2019
Q3
$285K Hold
2,550
0.16% 65
2019
Q2
$282K Sell
2,550
-1,140
-31% -$134K 0.16% 72
2019
Q1
$479K Buy
+3,690
New +$449K 0.29% 50

Other funds holding LLY

BHK Investment Advisors's LLY Position: Q4 2025 in Review

BHK Investment Advisors sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 557 shares — an estimated $425K sold.

BHK Investment Advisors first reported a position in LLY in Q1 2019 and held it in 27 quarters. The position peaked at $1.41M in Q2 2024. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • BHK Investment Advisors reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • BHK Investment Advisors sold 557 Eli Lilly shares in Q4 2025, an estimated $425K.
  • BHK Investment Advisors first reported a position in Eli Lilly in Q1 2019 and held it in 27 quarters.
  • BHK Investment Advisors's Eli Lilly position peaked at $1.41M in Q2 2024.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on BHK Investment Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.